Efficacy of (E)-5-(2-bromovinyl)-2′-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice

1982 ◽  
Vol 2 (5) ◽  
pp. 255-265 ◽  
Author(s):  
J. Reefschläger ◽  
P. Wutzler ◽  
K.-D. Thiel ◽  
D. Bärwolff ◽  
P. Langen ◽  
...  
2012 ◽  
Vol 51 (1) ◽  
pp. 356-359 ◽  
Author(s):  
Satsuki Kakiuchi ◽  
Shigeaki Nonoyama ◽  
Hajime Wakamatsu ◽  
Kazuhiro Kogawa ◽  
Lixin Wang ◽  
...  

1992 ◽  
Vol 3 (2) ◽  
pp. 85-94 ◽  
Author(s):  
D. Sutton ◽  
J. Taylor ◽  
T. H. Bacon ◽  
M. R. Boyd

Combinations of penciclovir (PCV) with other antiviral agents (acyclovir, ACV; ganciclovir, GCV; foscarnet, PFA; azido-thymidine, AZT) or with human interferons (HulFN-α,β,γ) were tested for inhibitory activity against herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) in cell culture. The antiviral interactions observed between combinations of PCV with ACV or GCV were purely additive. Combinations of PCV with HulFNs demonstrated highly synergistic anti-herpesvirus activity; some synergy was also detected between PCV and PFA against HSV-1. High concentrations of AZT inhibited the antiviral activity of PCV; this antagonism was competitive. In more detailed studies it was demonstrated that high concentrations of AZT also inhibited the antiviral activity of ACV, and that ACV was more sensitive to this antagonism than PCV. It was concluded that the antagonism was unlikely to have clinical significance.


Sign in / Sign up

Export Citation Format

Share Document